NCT07055516 - Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

May 8, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Obesity and Type 2 Diabetes

Interventions

DRUG

NT-0796

Orally administered capsules

DRUG

Placebo

Orally administered capsules

Trial Locations (11)

20110

RECRUITING

Investigative Site, Manassas

32127

RECRUITING

Investigative Site, Port Orange

32216

RECRUITING

Investigative Site, Jacksonville

33016

RECRUITING

Investigative Site, Hialeah

33024

RECRUITING

Investigative site, Cooper City

33147

RECRUITING

Investigative Site, Miami

43213

RECRUITING

Investigative Site, Columbus

70006

RECRUITING

Investigative Sites, Marrero

75230

RECRUITING

Investigative Site, Dallas

85225

RECRUITING

Investigative site, Mesa

90057

RECRUITING

Investigative site, Los Angeles

All Listed Sponsors

lead

NodThera Limited

INDUSTRY